ImmunoPrecise Antibodies's total assets for Q2 2025 were C$59.96M, an increase of 1.12% from the previous quarter. IPA total liabilities were C$27.29M for the fiscal quarter, a 3.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.